Key statistics
On Friday, Abcellera Biologics Inc (ABCL:NSQ) closed at 4.01, -7.39% below its 52-week high of 4.33, set on Jul 10, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.26 |
---|---|
High | 4.27 |
Low | 4.00 |
Bid | 4.00 |
Offer | 4.10 |
Previous close | 4.25 |
Average volume | 6.23m |
---|---|
Shares outstanding | 298.48m |
Free float | 212.55m |
P/E (TTM) | -- |
Market cap | 1.27bn USD |
EPS (TTM) | -0.5679 USD |
Data delayed at least 15 minutes, as of Jul 11 2025 21:00 BST.
More ▼
- AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025
- AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575
- AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause
- AbCellera’s Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit
- AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting
- AbCellera Reports Q1 2025 Business Results
- AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025
More ▼